Tubaro A - Search Results

1

The new Epstein gleason score classification significantly reduces upgrading in prostate cancer patients.

De Nunzio C, Pastore AL, Lombardo R, Simone G, Leonardo C, Mastroianni R, Collura D, Muto G, Gallucci M, Carbone A, Fuschi A, Dutto L, Witt JH, De Dominicis C, Tubaro A. De Nunzio C, et al. Among authors: tubaro a. Eur J Surg Oncol. 2018 Jun;44(6):835-839. doi: 10.1016/j.ejso.2017.12.003. Epub 2018 Jan 9. Eur J Surg Oncol. 2018. PMID: 29395435

2

Re: See W, Iversen P, Wirth M, McLeod D, Garside L, Morris T. Immediate treatment with bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostatic cancer. Eur Urol 2003;44:512-8.

Tubaro A, De Nunzio C. Tubaro A, et al. Eur Urol. 2004 May;45(5):674; author reply 674-5. doi: 10.1016/j.eururo.2004.01.006. Eur Urol. 2004. PMID: 15082213 No abstract available.

3

Local anesthesia reduces pain associated with transrectal prostatic biopsy. A prospective randomized study.

Trucchi A, De Nunzio C, Mariani S, Palleschi G, Miano L, Tubaro A. Trucchi A, et al. Among authors: tubaro a. Urol Int. 2005;74(3):209-13. doi: 10.1159/000083550. Urol Int. 2005. PMID: 15812205 Clinical Trial.

4

Open to debate. The motion: prevention of prostate cancer with a 5alpha-reductase inhibitor is feasible.

Roehrborn CG, Lotan Y, Tubaro A, de Nunzio C. Roehrborn CG, et al. Among authors: tubaro a. Eur Urol. 2006 Feb;49(2):396-400. doi: 10.1016/j.eururo.2005.12.059. Eur Urol. 2006. PMID: 16455190 No abstract available.

5

The effect of bladder outlet obstruction treatment on ultrasound-determined bladder wall thickness.

Tubaro A, De Nunzio C, Trucchi A, Palleschi G, Miano L. Tubaro A, et al. Rev Urol. 2005;7 Suppl 6(Suppl 6):S35-42. Rev Urol. 2005. PMID: 16986028 Free PMC article.

6

Transurethral needle ablation of the prostate.

Tubaro A, De Nunzio C, Miano R. Tubaro A, et al. Curr Opin Urol. 2007 Jan;17(1):7-11. doi: 10.1097/MOU.0b013e328011ab98. Curr Opin Urol. 2007. PMID: 17143104 Review.

7

Effect of once-daily alfuzosin on urinary symptoms and flow rate in benign prostatic hyperplasia : a 24-hour home-uroflowmetry evaluation.

De Nunzio C, Franco G, Leonardo C, Trucchi A, Tubaro A, Laurenti C. De Nunzio C, et al. Among authors: tubaro a. Clin Drug Investig. 2005;25(6):359-65. doi: 10.2165/00044011-200525060-00001. Clin Drug Investig. 2005. PMID: 17532676

8

Bipolar transurethral resection of prostate: clinical and urodynamic evaluation.

Iori F, Franco G, Leonardo C, Laurenti C, Tubaro A, D-Amico F, Dini D, De Nunzio C. Iori F, et al. Among authors: tubaro a. Urology. 2008 Feb;71(2):252-5. doi: 10.1016/j.urology.2007.09.064. Urology. 2008. PMID: 18308095 Clinical Trial.

9

The electromagnetic detection of prostatic cancer: evaluation of diagnostic accuracy.

Tubaro A, De Nunzio C, Trucchi A, Stoppacciaro A, Miano L. Tubaro A, et al. Urology. 2008 Aug;72(2):340-4. doi: 10.1016/j.urology.2007.11.058. Epub 2008 Mar 12. Urology. 2008. PMID: 18336888

10

Treatment options for benign prostatic hyperplasia in older men.

Miano R, De Nunzio C, Asimakopoulos AD, Germani S, Tubaro A. Miano R, et al. Among authors: tubaro a. Med Sci Monit. 2008 Jul;14(7):RA94-102. Med Sci Monit. 2008. PMID: 18591930 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

522 results

Search Page

Filters